Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
930 participants
INTERVENTIONAL
2021-07-01
2027-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For right-sided colon cancer, the laparoscopic right hemicolectomy (LRHC) knows substantial variation. Especially since the surgical technique has been evolving during the latest decade with the introduction of intracorporeal anastomosis, a dissection technique within the correct embryological planes (complete mesocolic excision) and central vascular ligation of the segmental branches at its origin, resulting in an optimal lymph node dissection.
Given the insights from recent studies showing the association between quality of surgery and relevant clinical outcomes, there is a great need for a formative quality assessment of LRHC. Detailed objective assessment of the LRHC is currently not performed in clinical practice nor in surgical training. Quality assessment of LRHC has great potential to improve surgical training and furthermore, implementation of a standardized technique will ultimately lead to better quality of care for patients suffering from right-sided colon cancer.
The main objective of this study is to improve surgical outcomes for patient with right-sided colon cancer by a prospective sequential interventional cohort study that aims to standardize the surgical technique with subsequent controlled implementation after standardized review of the current practice in a nationwide multicenter setting. The primary endpoint is the 30-day morbidity according to the Clavien-Dindo classification system.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intracorporeal vs. Extracorporeal Anastomosis in Patients Undergoing Laparoscopic Right Hemicolectomy for Colonic Cancer
NCT05039762
Study of the Intracorporeal Versus Extracorporeal Anastomosis in Right Hemicolectomy: HEMI-D-TREND-study
NCT03918369
Minimally Invasive Right Colectomy Anastomosis Study
NCT03650517
Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer
NCT04190589
Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection
NCT05077358
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. METC approval for the use of anonymized videos of a laparoscopic procedure and collection of corresponding clinical outcomes.
2. Approaching hospitals for participation (high volume centers (50+ colon cancers).
3. Prospective inclusion of consecutive patients undergoing laparoscopic right hemicolectomy in the participating hospitals in three months.
2. Development of Standard Laparoscopic Right Hemicolectomy: an (inter)national Delphi study
1. Approaching specialists to participate in the Delphi method (from participating hospitals in step 1).
2. Identification of crucial steps and measures according to literature and expert's opinion (Delphi method).
3. Documentation of steps and the order in which they need to be performed, development of a competency assessment tool (CAT).
3. Skills center training facility
a. Training the participating surgeons in the method of the standardized laparoscopic right hemicolectomy, as consented in the Delphi method.
4. Implementation of the standardized laparoscopic right hemicolectomy with proctoring during another period with prospective inclusion of consecutive patients with collection of surgical videos in all participating hospitals (N=40 centers, total 310 videos)
1. Rating videos.
2. Comparing with pre-implementation performance based on outcome measures reflecting oncological quality of surgery, and 30-day clinical outcomes.
3. Comparing with pre-implementation performance based on the long-term outcomes. (3-year DFS and 5-year OS).
5. Implementing standardised lap right hemicolectomy (after learning curve without proctoring)
1. Consecutive inclusion of patients (n=310)
2. CT imaging
3. Video analysis
4. Competency analysis
5. Variation analysis
6. Clinico pathological data
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical variations laparoscopic right hemicolectomy
No interventions assigned to this group
Implementing standardised laparoscopic right hemicolectomy with proctoring
Implementation standardised laparoscopic right hemicolectomy with proctoring
Implementation standardised laparoscopic right hemicolectomy with proctoring
Implementing standardised laparoscopic right hemicolectomy without proctoring
Implementation standardised laparoscopic right hemicolectomy without proctoring
Implementation standardised laparoscopic right hemicolectomy without proctoring
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implementation standardised laparoscopic right hemicolectomy with proctoring
Implementation standardised laparoscopic right hemicolectomy with proctoring
Implementation standardised laparoscopic right hemicolectomy without proctoring
Implementation standardised laparoscopic right hemicolectomy without proctoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age above 18 years;
* cTNM stage 1-3 (CT-staged);
* No prior midline or transverse laparotomy;
* ASA1-3;
* No immune modulating medication.
Exclusion Criteria
* Perforated disease;
* Acute obstruction;
* Emergency operation;
* Appendiceal cancer;
* Other primary malignancy treated within 5 years from diagnosis of colon cancer, except for curatively treated prostate, breast, skin and cervical cancer.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. dr. P.J. Tanis, colorectal surgeon
UNKNOWN
Dr. B.R. Toorenvliet, colorectal surgeon
UNKNOWN
D. Miskovic, St Marks hospital London, UK
UNKNOWN
S. Benz, Klinikverbund SuedWest, Böblingen, Germany
UNKNOWN
F. Aigner, Krankenhaus der Barmherzigen Bruder, Graz, Austria
UNKNOWN
C.A. Bertelsen, Hillerød University Hospital, Copenhagen, Denmark
UNKNOWN
Drs. A.A.J. Grüter
UNKNOWN
Dr. U.K. Coblijn
UNKNOWN
Dr. H.L. van Westreenen
UNKNOWN
Dr. C. Sietses
UNKNOWN
Prof. dr. E.C.J. Consten
UNKNOWN
Dr. A.W.H. van de Ven
UNKNOWN
Dr. P. van Duijvendijk
UNKNOWN
Dr. S. van Aalten
UNKNOWN
Dr. F. den Boer
UNKNOWN
Dr. J.W.A. Leijtens
UNKNOWN
Dr. C. Hoff
UNKNOWN
Dr. O. van Ruler
UNKNOWN
Dr. G. D. Slooter
UNKNOWN
Prof. dr. J. Lange
UNKNOWN
Prof. dr. G.J. Kleinrensink
UNKNOWN
Amsterdam UMC, location VUmc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jurriaan B. Tuynman
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC, location VUmc
Amsterdam, North Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Gruter AAJ, Coblijn UK, Toorenvliet BR, Tanis PJ, Tuynman JB; Right Collaborators Group. National implementation of an optimal standardised technique for right-sided colon cancer: protocol of an interventional sequential cohort study (Right study). Tech Coloproctol. 2023 Nov;27(11):1083-1090. doi: 10.1007/s10151-023-02801-6. Epub 2023 Apr 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021.0273
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.